Figure 3.
Kaplan-Meier estimates of OS in 61 patients with MF treated with JAKis by the presence or absence of RAS/CBLMTs.

Kaplan-Meier estimates of OS in 61 patients with MF treated with JAKis by the presence or absence of RAS/CBLMTs.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal